Product Information
RIVASTIGMINE 6 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1638 per EA under NDC 62332006660. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
6 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332006660
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091689On Market Since
6/12/2022
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 6 MG CAPSULE has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1638 per EA |
|---|---|
| All-time high | $0.3875 (Jan 10, 2024) |
| All-time low | $0.1548 (Jul 17, 2024) |
| 52-week high | $0.2384 |
| 52-week low | $0.1638 |
| Median price | $0.2191 |
| Average price | $0.2278 |
| Largest weekly change | +58.0% (Dec 20, 2023) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 6 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 6 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.1638 per EA (NDC 62332006660), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 6 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 6 MG CAPSULE has declined 45.1%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 6 MG CAPSULE?
Since Aug 10, 2022, the NADAC for RIVASTIGMINE 6 MG CAPSULE has ranged from a low of $0.1548 (Jul 17, 2024) to a high of $0.3875 (Jan 10, 2024), with a median of $0.2191 per EA.
Are there cheaper alternatives to RIVASTIGMINE 6 MG CAPSULE?
5 NADAC-published products share the same active ingredient, strength, and dosage form as RIVASTIGMINE 6 MG CAPSULE, but none are currently priced below it.
Who manufactures RIVASTIGMINE 6 MG CAPSULE?
RIVASTIGMINE 6 MG CAPSULE (NDC 62332006660) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification